These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21937968)

  • 41. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. IV. Application of long polymerase chain reaction for identification of CYP2D6 gene duplication.
    Pułczyńska A; Łukaszkiewicz J; Wojnar M; Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2011; 68(1):9-13. PubMed ID: 21485696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CYP2D6 genotypes in Puerto Rican psychiatry patients with intolerance of antidepressants and antipsychotics.
    Gonzalez-Tejera GM; Corey S
    Bol Asoc Med P R; 2009; 101(1):7-12. PubMed ID: 19954080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depression diagnosis and antidepressant treatment among depressed VA primary care patients.
    Liu CF; Campbell DG; Chaney EF; Li YF; McDonell M; Fihn SD
    Adm Policy Ment Health; 2006 May; 33(3):331-41. PubMed ID: 16755394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressant direct-to-consumer advertising and social perception of the prevalence of depression: application of the availability heuristic.
    An S
    Health Commun; 2008 Nov; 23(6):499-505. PubMed ID: 19089697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants].
    Jeleń A; Sałagacka A; Balcerczak E
    Postepy Hig Med Dosw (Online); 2015 Jul; 69():753-62. PubMed ID: 26206991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacology of antidepressants.
    Richelson E
    Mayo Clin Proc; 2001 May; 76(5):511-27. PubMed ID: 11357798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacogenetic challenges in the treatment of mental diseases].
    Sukhanov VA; Piruzian LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):83-6. PubMed ID: 15554149
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacogenomics in depression and antidepressants.
    Bondy B
    Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies.
    Fabbri C; Serretti A
    Neurosci Lett; 2020 May; 726():133651. PubMed ID: 29906483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depression and Pharmacogenetics.
    Ampong DN
    Arch Psychiatr Nurs; 2018 Feb; 32(1):71-74. PubMed ID: 29413077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depression and pharmacogenetics: A psychiatric pharmacist's perspective.
    McGrane IR; Mertens S
    Arch Psychiatr Nurs; 2018 Jun; 32(3):329-330. PubMed ID: 29784209
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cytochrome pharmacogenetics applied to the prescription of antidepressants: Instructions for use].
    Baldacci A; Saguin E; Annette S; Lahutte B; Colas MD; Delacour H
    Encephale; 2022 Aug; 48(4):462-471. PubMed ID: 35331467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrence of Serotonin Toxicity and Influence of Cytochrome 2D6 Polymorphism.
    Volon B; Willemart T; Haufroid V; Hantson P
    Prim Care Companion CNS Disord; 2019 Nov; 21(6):. PubMed ID: 31794166
    [No Abstract]   [Full Text] [Related]  

  • 55. Trends in antidepressant use among U.S. cancer survivors, 1999-2012.
    Xiang X; An R; Gehlert S
    Psychiatr Serv; 2015 Jun; 66(6):564. PubMed ID: 25930047
    [No Abstract]   [Full Text] [Related]  

  • 56. Cytochrome P450 2D6 poor metabolism, curvilinearity, and response: an intriguing observation requiring integration of psychopharmacology into pharmacogenetics.
    Al Hadithy AF; Birkenhager TK; Koch BC
    J Clin Psychopharmacol; 2013 Dec; 33(6):833-4. PubMed ID: 24196656
    [No Abstract]   [Full Text] [Related]  

  • 57. The pharmacological management of depression.
    Kupfer DJ
    Dialogues Clin Neurosci; 2005; 7(3):191-205. PubMed ID: 16156378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impulsivity, irritability, and depression: antidepressants.
    Mullen DJ; Terry J
    Adolesc Med State Art Rev; 2013 Aug; 24(2):406-19, viii. PubMed ID: 24298755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Genetic tests for controlling treatment with antidepressants].
    Bschor T; Baethge C; Hiemke C; Müller-Oerlinghausen B
    Nervenarzt; 2017 May; 88(5):495-499. PubMed ID: 28303314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressant Use Among Persons Aged 12 and Over:United States,2011-2014.
    Pratt LA; Brody DJ; Gu Q
    NCHS Data Brief; 2017 Aug; (283):1-8. PubMed ID: 29155679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.